Galectin Therapeutics Inc (GALT) financials · $142.4M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Galectin Therapeutics Inc (GALT) $142.4M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Income | -$20.1M | -$42.4M |
| Net Income | -$30.8M | -$47.0M |
| EPS (Diluted) | -$0.48 | -$0.76 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $19.5M | $17.5M |
| Current Assets | $19.4M | $17.3M |
| Cash & Equivalents | $17.7M | $15.1M |
| PP&E | N/A | N/A |
| Total Liabilities | $145.7M | $120.6M |
| Current Liabilities | $8.03M | $35.4M |
| Shareholders' Equity | -$127.9M | -$104.8M |
| Retained Earnings | -$432.5M | -$401.6M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$23.9M | -$41.8M |
| Investing Cash Flow | N/A | N/A |
| Financing Cash Flow | $26.5M | $31.2M |
FAQ
What is GALT P/E and revenue?
Galectin Therapeutics Inc (GALT) $142.4M cap.
What is GALT revenue?
GALT income-statement cache has no revenue figure yet.
Is GALT profitable?
Galectin Therapeutics Inc last cached net income is -$30.8M (FY2025).
What are GALT total assets?
Galectin Therapeutics Inc last cached total assets are $19.5M (FY2025).
What is GALT free cash flow?
No cached cash-flow row for GALT yet.
Not investment advice. Cached statements, not a live tape.